Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

T-Investments broker resumed trading in a number of blocked securities

12/19/24 T

UTair passenger traffic on airplanes in January-November increased by 5.5%

12/19/24 UTAR

Samolet launches closed-end rental real estate mutual fund

12/19/24 SMLT

Delimobil has multiplied the revenue from carsharing for business

12/19/24 DELI

En+ Group suspends giant wind farm project in Blagoveshchensk

12/19/24 ENPG

Shareholders of Ozon Pharmaceuticals approved dividends

12/18/24 OZPH

Alrosa's production volume by the end of the year will amount to 33 mln carats

12/18/24 ALRS

Gazprom shipped LNG to Italy for the first time from the Portovaya terminal

12/18/24 GAZP

Samolet will conduct a bond buyback

12/18/24 SMLT

Ozone Pharmaceuticals has started clinical trials of a biotech drug

12/18/24 OZPH